Rain Therapeutics Inc. (RAIN) stock declined over -3.24% intraday to trade at $5.38 a share on NASDAQ. The stock opened with a gain of 11.39% at $5.69 and touched an intraday high of $6.2, falling -3.24% against the last close of $5.56. The stock went to a low of $4.36 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinical trial for intimal sarcoma, as well as RAD52 which is in preclinical trials for tumors, including breast, ovarian, pancreatic, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.
Rain Therapeutics Inc. (NASDAQ: RAIN) stock price is $5.38 as of the last check on Friday, July 1. During the trading session, RAIN stock reached the peak price of $6.2 while $4.36 was the lowest point it dropped to.
The NASDAQ listed RAIN is part of Pharmaceuticals industry that operates in the broader Health Care sector. Rain Therapeutics Inc. , a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States.
Dr. Robert C. Doebele M.D., Ph.D.
Co-Founder, Chairman of Scientific Advisory Board, Pres & Chief Scientific Officer
Mr. Lucio Tozzi
Sr. VP of Clinical Operations
Kolbot By Ph.D.
Sr. VP of Technical Operations
Mr. Avanish Vellanki M.B.A.
Co-Founder, CEO & Chairman
RAIN stock traded closed the last session at $5.38, which is $-0.18 or -3.24% lower than its previous close of $5.56. RAIN's current trading price is 150.23% lower than its 52-week high of $22.22 where as its distance from 52-week low of 2.15% is -75.79%.
Number of RAIN employees currently stands at -. RAIN operates from 8000 Jarvis Avenue, Suite 204, Newark, CA 94560, United States.
Official Webiste of $RAIN is: https://www.rainthera.com
RAIN stock volume for the day was 613,940 shares while in the previous session number of RAIN shares traded was 613,900 . The average number of RAIN shares traded daily for last 3 months was 192.6 Thousands.
The percentage change in RAIN stock occurred in the recent session was -3.24% while the dollar amount for the price change in RAIN stock was $-0.18.
In the recent session, the day high for RAIN stock was $6.2 while the low for RAIN stock touched on the day was $4.36.
The market value of RAIN currently stands at 147.52 Million with its latest stock price at $5.38 and 26.51 Million of its shares outstanding.